Invitrogen™ Peptide synthétique SCNN1B (aa 619-640) humain

Réf. : BL-RE-175456Réf. fabricant : PEP089 50 μg
189,00 € HT

Human beta-ENaC (residues 619-640) Synthetic Peptide, PEP-089, from Invitrogen.

Gene ID (Entrez)
6338
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
P51168
Nom usuel
Human SCNN1B (aa 619-640)
Marque
Invitrogen

Human beta-ENaC (residues 619-640) Synthetic Peptide, PEP-089, from Invitrogen.

Human beta-ENaC (residues 619-640) Synthetic Peptide, PEP-089, from Invitrogen.

Sodium permeable non-voltage-sensitive ion channel inhibited by the diuretic amiloride. Mediates the electrodiffusion of the luminal sodium (and water, which follows osmotically) through the apical membrane of epithelial cells. Controls the reabsorption of sodium in kidney, colon, lung and sweat glands. Also plays a role in taste perception. Heterotetramer of two alpha, one beta and one gamma subunit. A delta subunit can replace the alpha subunit. Interacts with the WW domains of NEDD4, NEDD4L, WWP1 and WWP2. Defects in SCNN1B are a cause of autosomal recessive pseudohypoaldosteronism type 1 (PHA1) [MIM:264350]. PHA1 is a rare salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. There are 2 forms of PHA1: the autosomal recessive form that is severe, and the dominant form which is more milder and due to defects in mineralocorticoid receptor. Autosomal recessive PHA1 is characterized by an often fulminant presentation in the neonatal period with dehydration, hyponatraemia, hyperkalaemia, metabolic acidosis, failure to thrive and weight loss. Defects in SCNN1B are a cause of Liddle syndrome. It is an autosomal dominant disorder characterized by pseudoaldosteronism and hypertension associated with hypokalemic alkalosis. The disease is caused by constitutive activation of the renal epithelial sodium channel.

Espèces

Espèces : Humaine.

Conservation

Conservation : -20°C. Avoid freeze-thaw cycles.

Formulation

Concentration : 0,5 mg/mL.

Statut réglementaire

Réservé à la recherche (RUO).

Conditionnement

Conditionnement : 50 μg.

Caractéristiques techniques

Général
MarqueInvitrogen
Réf. fournisseur (Fisher Scientific)11574740
Caractéristiques
Gene ID (Entrez)6338
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionP51168
Nom usuelHuman SCNN1B (aa 619-640)
Concentration0.5 mg/mL
DescriptionSynthetic Peptide
FormatLyophilized
Formulepeptide with no preservative
À utiliser avec (application)Control
Symbole de gène(s)SCNN1B
LyophiliséLyophilized
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
SéquenceC N(619)-Y-D-S-L-R-L-Q-P-L-D-V-I-E-S-D-S-E-G-D-A-I(640)
Stockage et expédition
Contenu et stockage-20°C. Avoid freeze-thaw cycles.
ConservateurNo preservative

Origine et douane

Réf. fabricantPEP089
Pays d’origineÉtats-Unis
Code douanier (SH)2934 99 90 00
Une question, une configuration particulière ?
Contactez-nous pour un devis.